Skip to main content

letter

. 1990 Oct;45(10):777. doi: 10.1136/thx.45.10.777

Investigation of pulmonary disease in HIV infection.

P J Flegg, L J Willocks, R P Brettle, A G Bird

PMCID: PMC462732 PMID: 2247873

777

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Selwyn P. A., Feingold A. R., Hartel D., Schoenbaum E. E., Alderman M. H., Klein R. S., Friedland G. H. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS. 1988 Aug;2(4):267–272. doi: 10.1097/00002030-198808000-00005. [DOI] [PubMed] [Google Scholar]
Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]
Stoneburner R. L., Des Jarlais D. C., Benezra D., Gorelkin L., Sotheran J. L., Friedman S. R., Schultz S., Marmor M., Mildvan D., Maslansky R. A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science. 1988 Nov 11;242(4880):916–919. doi: 10.1126/science.3187532. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES